Insulin glargine use during pregnancy

Endocrine Practice

Volumn 17, Issue 3, 2011, Pages 448-455

  Pantalone, Kevin M ^a,b   Faiman, Charles ^a   Olansky, Leann ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

^b NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HUMAN INSULIN; INSULIN GLARGINE;

BIOSIS; CONCEPTION; CONTROLLED STUDY; DIABETES MELLITUS; FEMALE; FIRST TRIMESTER PREGNANCY; GLYCEMIC CONTROL; HUMAN; MAJOR CLINICAL STUDY; MEDLINE; MITOGENICITY; PATIENT SAFETY; PLACENTAL TRANSFER; PREGNANCY; REVIEW;

DIABETES, GESTATIONAL; FEMALE; HUMANS; HYPOGLYCEMIC AGENTS; INSULIN; MODELS, BIOLOGICAL; PREGNANCY; PREGNANCY COMPLICATIONS; PREGNANCY IN DIABETICS;

EID: 79959647270     PISSN: 1530891X     EISSN: 19342403     Source Type: Journal    
DOI: 10.4158/EP11083.RA     Document Type: Review

References (67)

1. Kurtzhals P, Schäffer L, Sørensen A, et al. Correlations of receptor binding and metabolic and mitogenic potencies of insulin analogs designed for clinical use. Diabetes. 2000;49:999-1005. (Pubitemid 30349423)
2. Mills JL, Baker L, Goldman AS. Malformations in infants of diabetic mothers occur before the seventh gestational week. Implications for treatment. Diabetes. 1979;28:292-293. (Pubitemid 9176775)
3. Pedersen J. Weight and length at birth of infants of diabetic mothers. Acta Endocrinol (Copenh). 1954;16:330-342.
4. Ferber A. Maternal complications of fetal macrosomia. Clin Obstet Gynecol. 2000;43:335-339. (Pubitemid 30450547)
5. Grassi AE, Giuliano MA. The neonate with macrosomia. Clin Obstet Gynecol. 2000;43:340-348. (Pubitemid 30450548)
6. Spellacy WN, Miller S, Winegar A, Peterson PQ. Macrosomia-maternal characteristics and infant complications. Obstet Gynecol. 1985;66:158-161.
7. Skyler JS, O'Sullivan MJ, Holsinger KK. The relationship between maternal glycemia and macrosomia. Diabetes Care. 1980;3:433-434. (Pubitemid 10000689)
8. Tyrala EE. The infant of the diabetic mother. Obstet Gynecol Clin North Am. 1996;23:221-241. (Pubitemid 26084173)
9. Sciacca L, Marotta V, Insalaco F, et al. Use of insulin detemir during pregnancy. Nutr Metab Cardiovasc Dis. 2010;20:e15-e16.
10. Lapolla A, Di Cianni G, Bruttomesso D, et al. Use of insulin detemir in pregnancy: A report on 10 type 1 diabetic women. Diabet Med. 2009;26:1181-1182.
11. Todorova-Ananieva K, Genova M. Pregnancy outcomes in women with type 1 diabetes treated with long-acting insulin analogues. A case control study. Abstract presented at: 44th EASD Annual Meeting of the European Association for the Study of Diabetes; September 8-11, 2008; Rome, Italy.
12. Berger M. Safety of insulin glargine. Lancet. 2000;356: 2013-2014.
13. Ciaraldi TP, Carter L, Seipke G, Mudaliar S, Henry RR. Effects of the long-acting insulin analog insulin glargine on cultured human skeletal muscle cells: Comparisons to insulin and IGF-I. J Clin Endocrinol Metab. 2001;86:5838-5847. (Pubitemid 33152632)
14. Bolli GB, Owens DR. Insulin glargine. Lancet. 2000;356: 443-445. (Pubitemid 30496809)
15. Ciaraldi TP, Sasaoka T. Review on the in vitro interaction of insulin glargine with the insulin/insulin-like growth factor system: Potential implications for metabolic and mitogenic activities. Horm Metab Res. 2011;43:1-10.
16. Agin A, Jeandidier N, Gasser F, Grucker D, Sapin R. Glargine blood biotransformation: In vitro appraisal with human insulin immunoassay. Diabetes Metab. 2007;33: 205-212. (Pubitemid 46863409)
17. Kuerzel GU, Shukla U, Scholtz HE, et al. Biotransformation of insulin glargine after subcutaneous injection in healthy subjects. Curr Med Res Opin. 2003; 19:34-40. (Pubitemid 36378318)
18. Sommerfeld MR, Müller G, Tschank G, et al. In vitro metabolic and mitogenic signaling of insulin glargine and its metabolites. PLoS One. 2010;5:e9540.
19. Keller JM, Krohmer JS. Insulin transfer in the isolated human placenta. Obstet Gynecol. 1968;32:77-80.
20. Challier JC, Hauguel S, Desmaizieres V. Effect of insulin on glucose uptake and metabolism in the human placenta. J Clin Endocrinol Metab. 1986;62:803-807. (Pubitemid 16106699)
21. Boskovic R, Feig DS, Derewlany L, Knie B, Portnoi G, Koren G. Transfer of insulin lispro across the human placenta: In vitro perfusion studies. Diabetes Care. 2003;26: 1390-1394. (Pubitemid 36929168)
22. Pollex EK, Feig DS, Lubetsky A, Yip PM, Koren G. Insulin glargine safety in pregnancy: A transplacental transfer study. Diabetes Care. 2010;33:29-33.
23. Menon RK, Cohen RM, Sperling MA, Cutfield WS, Mimouni F, Khoury JC. Transplacental passage of insulin in pregnant women with insulin-dependent diabetes mellitus. Its role in fetal macrosomia. N Engl J Med. 1990;323:309-315. (Pubitemid 20237096)
24. Ludwig SM, Faiman C, Dean HJ. Insulin and insulin-receptor autoantibodies in children with newly diagnosed IDDM before insulin therapy. Diabetes. 1987;36:420-425. (Pubitemid 18023183)
25. Ottesen JL, Nilsson P, Jami J, et al. The potential immunogenicity of human insulin and insulin analogues evaluated in a transgenic mouse model. Diabetologia. 1994;37:1178-1185. (Pubitemid 24356756)
26. Sahin SB, Cetinkalp S, Ozgen AG, Saygili F, Yilmaz C. The importance of anti-insulin antibody in patients with type 1 diabetes mellitus treated with continuous subcutaneous insulin infusion or multiple daily insulin injections therapy. Acta Diabetol. 2010;47:325-330.
27. Lantus [package insert]. Bridgewater, NJ: Sanofi-aventis U.S.; 2009.
28. Hofmann T, Horstmann G, Stammberger I. Evaluation of the reproductive toxicity and embryotoxicity of insulin glargine (LANTUS) in rats and rabbits. Int J Toxicol. 2002;21:181-189. (Pubitemid 34803493)
29. Devlin JT, Hothersall L, Wilkis JL. Use of insulin glargine during pregnancy in a type 1 diabetic woman. Diabetes Care. 2002;25:1095-1096.
30. Holstein A, Plaschke A, Egberts EH. Use of insulin glargine during embryogenesis in a pregnant woman with type 1 diabetes. Diabet Med. 2003;20:779-780. (Pubitemid 43291776)
31. Dolci M, Mori M, Baccetti F. Use of glargine insulin before and during pregnancy in a woman with type 1 diabetes and Addison's disease. Diabetes Care. 2005;28:2084-2085. (Pubitemid 41061000)
32. Di Cianni G, Volpe L, Lencioni C, et al. Use of insulin glargine during the first weeks of pregnancy in five type 1 diabetic women. Diabetes Care. 2005;28:982-983. (Pubitemid 40434513)
33. Woolderink JM, van Loon AJ, Storms F, de Heide L, Hoogenberg K. Use of insulin glargine during pregnancy in seven type 1 diabetic women. Diabetes Care. 2005;28:2594-2595. (Pubitemid 41384328)
34. Graves DE, White JC, Kirk JK. The use of insulin glargine with gestational diabetes mellitus. Diabetes Care. 2006;29:471-472. (Pubitemid 44106552)
35. Kirss A. Use of glargine insulin before and during pregnancy in Tartu University Women's Clinic [abstract]. Diabet Med. 2006;23(Suppl 4):504. Abstract P1410.
36. Araujo C, Arrais Araujo C, Pitombo L, Lemos N. Use of insulin glargine during pregnancy in ten type 1 diabetic women. Abstract presented at: The Endocrine Society's 88th Annual Meeting; June 24-27, 2006; Boston, MA. Abstract P2-853.
37. Caronna S, Cioni F, Dall'Aglio E, Arsenio L. Pregnancy and the long-acting insulin analogue: A case study. Acta Biomed 2006;77:24-26.
38. Ghosh D, Graham D, Street P, Elsheikh M. Use of insulin glargine during pregnancy in women with type 1 diabetes mellitus. Abstract presented at the 8th European Congress of Endocrinology; April 1-5, 2006; Glasgow, UK. Abstract P322.
39. Tahrani AA, Varughese GI, Wilkins JD, Taylor SE, Hanna FW. Glargine in pregnant patients with type 1 diabetes. Diabet Med. 2008;25:111-112.
40. Torlone E, Gennarini A, Ricci NB, Bolli GB. Successful use of insulin glargine during entire pregnancy until delivery in six type 1 diabetic women. Eur J Obstet Gynecol Reprod Biol. 2007;132:238-239. (Pubitemid 46817711)
41. Gallen IW, Jaap A, Roland JM, Chirayath HH. Survey of glargine use in 115 pregnant women with type 1 diabetes. Diabet Med. 2008;25:165-169. (Pubitemid 351293402)
42. Di Cianni G, Torlone E, Lencioni C, et al. Perinatal outcomes associated with the use of glargine during pregnancy. Diabet Med. 2008;25:993-996.
43. Henderson CE, Machupalli S, Marcano-Vasquez H, Kerr P, Reilly KD. A retrospective review of glargine use in pregnancy. J Reprod Med. 2009;54:208-210.
44. Lepercq J, Jacqueminet S, Hieronimus S, Timsit J, Grimaldi A. Use of insulin glargine throughout pregnancy in 102 women with type 1 diabetes. Diabetes Metab. 2010;36:209-212.
45. Casson IF, Clarke CA, Howard CV, et al. Outcomes of pregnancy in insulin dependent diabetic women: Results of a five year population cohort study. BMJ. 1997;315:275-278. (Pubitemid 27326208)
46. Penney GC, Mair G, Pearson DW; Scottish Diabetes in Pregnancy Group. Outcomes of pregnancies in women with type 1 diabetes in Scotland: A national population-based study. BJOG. 2003;110:315-318. (Pubitemid 36298919)
47. Jensen DM, Damm P, Moelsted-Pedersen L, et al. Outcomes in type 1 diabetic pregnancies: A nationwide, population-based study. Diabetes Care 2004;27:2819-2823. (Pubitemid 39565043)
48. Evers IM, de Valk HW, Visser GH. Risk of complications of pregnancy in women with type 1 diabetes: Nationwide prospective study in the Netherlands. BMJ. 2004;328:915.
49. Macintosh MC, Fleming KM, Bailey JA, et al. Perinatal mortality and congenital anomalies in babies of women with type 1 or type 2 diabetes in England, Wales, and Northern Ireland: Population based study. BMJ. 2006;333:177.
50. Lapolla A, Dalfrà MG, Di Cianni G, Bonomo M, Parretti E, Mello G; Scientific Committee of the GISOGD Group. A multicenter Italian study on pregnancy outcome in women with diabetes. Nutr Metab Cardiovasc Dis. 2008;18:291-297. (Pubitemid 351707608)
51. Meltzer SJ, Ryan EA, Feig DS, Thompson D, Snyder J. Preconception care for women with diabetes. Canadian Diabetes Association, clinical practice guidelines, 2003.
52. Feisullin K, Ness A, Baxter J. A cohort study of insulin glargine in diabetic pregnancies. Abstract presented at: The 27th Annual Meeting of the Society-of-Maternal-Fetal-Medicine. February 5 -10, 2007; San Francisco, CA. Am J Obstet Gynecol. 2007;195 (6 Suppl 1):S145. Abstract 465.
53. Hothersall LA, Caron E, Mullin K, Devlin JT. Insulin glargine versus NPH for managing diabetes in pregnancy. Abstract presented at: The 66th Annual Meeting of the American Diabetes Association; June 9-13, 2006; Washington, DC. Diabetes. 2006;55(Suppl 1):A605. Abstract 2616-PO.
54. Pöyhönen-Alho M, Rönnemaa T, Saltevo J, Ekblad U, Kaaja RJ. Use of insulin glargine during pregnancy. Acta Obstet Gynecol Scand. 2007;29:1-4.
55. Price N, Bartlett C, Gillmer M. Use of insulin glargine during pregnancy: A case-control pilot study. BJOG. 2007; 114:453-457. (Pubitemid 46393280)
56. Imbergamo MP, Amato MC, Sciortino G, et al. Use of glargine in pregnant women with type 1 diabetes mellitus: A case-control study. Clin Ther. 2008;30:1476-1484.
57. Fang YM, MacKeen D, Egan JF, Zelop CM. Insulin glargine compared with neutral protamine Hagedorn insulin in the treatment of pregnant diabetics. J Matern Fetal Neonatal Med. 2009;22:249-253.
58. Egerman RS, Ramsey RD, Kao LW, et al. Perinatal outcomes in pregnancies managed with antenatal insulin glargine. Am J Perinatol. 2009;26:591-595.
59. Smith JG, Manuck TA, White J, Merrill DC. Insulin glargine versus neutral protamine Hagedorn insulin for treatment of diabetes in pregnancy. Am J Perinatol. 2009; 26:57-62.
60. Negrato CA, Rafacho A, Negrato G, et al. Glargine vs. NPH insulin therapy in pregnancies complicated by diabetes: An observational cohort study. Diabetes Res Clin Pract. 2010;89:46-51.
61. Pantalone KM, Agarwal S, Faiman C. Glargine vs. NPH insulin therapy in pregnancies complicated by diabetes: An observational cohort study-comment on Negrato et al. Diabetes Res Clin Pract. 2011 Apr 18 [Epub ahead of print].
62. Pollex E, Moretti ME, Koren G, Feig DS. Safety of insulin glargine use in pregnancy: A systematic review and meta-analysis. Ann Pharmacother. 2011;45:9-16.
63. Koldovský O. Hormones in milk. Vitam Horm. 1995;50: 77-149.
64. Kulski JK, Hartmann PE. Milk insulin, GH and TSH: Relationship to changes in milk lactose, glucose and protein during lactogenesis in women. Endocrinol Exp. 1983; 17:317-326.
65. Shehadeh N, Gelertner L, Blazer S, Perlman R, Solovachik L, Etzioni A. Importance of insulin content in infant diet: Suggestion for a new infant formula. Acta Paediatr. 2001;90:93-95. (Pubitemid 32147234)
66. Whitmore TJ, Trengove NJ, Hartmann PE. Insulin content of human milk [abstract]. Breastfeed Med. 2008;3: 83-84.
67. Ratner RE, Hirsch IB, Neifing JL, Garg SK, Mecca TE, Wilson CA. Less hypoglycemia with insulin glargine in intensive insulin therapy for type 1 diabetes. U.S. study group of insulin glargine in type 1 diabetes. Diabetes Care. 2000;23:639-643. (Pubitemid 30321544)